Scientific publications

Featured recent publications

Long term treatment effect of ETI

Bronchi
BA, MP
Treatment efficacy
Cystic Fibrosis

June 2026

Annals of the American Thoracic Society

Impact of two years of treatment with ETI on longitudinal changes in structural lung disease in people with Cystic Fibrosis

Combining Imaging with Inflammation insights

Bronchi
BA
Exploratory, Treatment efficacy
Cystic Fibrosis

June 2026

American Journal of Respiratory and Critical Care Medicine

Correlation Between Segmental Bronchial Wall Thickness and Bronchoalveolar Lavage Markers of Inflammation and Mucus Before and After Elexacaftor-Tezacaftor-Ivacaftor Therapy

Mucus reduction response assessment

Bronchi, Parenchyma
BA, VERA
Treatment efficacy
COPD-chronic airway disease

February 2026

European Respiratory Journal

The effects of metered cryospray on quantitative computed tomography metrics in patients with COPD with chronic bronchitis

Navigation Bronchoscopy planning

Bronchi
Airway Analysis
Exploratory, Performance validation
Bronchoscopic Interventions, COPD

November 2025

European Respiratory Journal

Quality of CT based airway segmentation software for navigation bronchoscopy

Phenotyping intra-patient heterogeneity

Bronchi
BA
Performance validation
Bronchiectasis disease

November 2025

European Respiratory Journal

Lobar differences on chest CTs of bronchiectasis patients from the EMBARC registry

Quantification of ETI treatment effect in CF

Bronchi
BA, MP
Treatment efficacy
Cystic Fibrosis

October 2025

The Lancet Respiratory Medicine

Effect of elexacaftor–tezacaftor–ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study

All Publications

European Respiratory Journal | September 2026

Bronchial segmental heterogeneity of responsiveness to modulator therapy in cystic fibrosis: linking structural improvements on computed tomography to inflammation in bronchoalveolar lavage fluid (to be published)

European Respiratory Journal | August 2026

Response to endobronchial valve treatment: it’s all about the target lobe

European Respiratory Journal | August 2026

Identification of CT-based Structural Alterations Resembling COPD in Individuals Without Airflow Obstruction (to be presented at ERS2026)

Annals of the American Thoracic Society | June 2026

Impact of two years of treatment with ETI on longitudinal changes in structural lung disease in people with Cystic Fibrosis

Journal of COPD Foundation | June 2026

Small Pulmonary Artery and Vein Volumes Independently Predict Oxygen Desaturation in Smokers

American Journal of Respiratory and Critical Care Medicine | June 2026

Correlation Between Segmental Bronchial Wall Thickness and Bronchoalveolar Lavage Markers of Inflammation and Mucus Before and After Elexacaftor-Tezacaftor-Ivacaftor Therapy

American Journal of Respiratory and Critical Care Medicine | June 2026

AI-Based Quantitative CT Can Characterize Structural Heterogeneity in Pi*ZZ Alpha-1 Antitrypsin Deficiency

American Journal of Respiratory and Critical Care Medicine | June 2026

Concordance of Visual and Artificial Intelligence-Based Mucus Plug Detection on Computed Tomography in the COPDgene Study

American Journal of Respiratory and Critical Care Medicine | June 2026

AI-driven Quantitative CT Analysis of Structural Lung Changes After Benralizumab in Severe Asthma

American Journal of Respiratory and Critical Care Medicine | June 2026

Quantitative CT Analysis for Monitoring Mycobacteriophage Therapy in a Cystic-Fibrosis Patient With a Mycobacterium Abscessus Pulmonary Infection